Related Experiment Video
Updated: Jan 19, 2026

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.4K
Coordinating a new approach to basic research into Parkinson's disease.
Randy Schekman1, Ekemini Au Riley2
1Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, United States.
Elife
|September 26, 2019
Summary
The Aligning Science Across Parkinson's (ASAP) initiative fosters global research collaboration to understand Parkinson's disease biology. This network aims to uncover disease origins and progression for developing novel therapeutic strategies.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease (PD) is a complex neurodegenerative disorder with incompletely understood etiology.
- Current therapeutic strategies primarily manage symptoms, highlighting the need for disease-modifying treatments.
- The existing research landscape for PD is fragmented, necessitating enhanced collaboration.
Purpose of the Study:
- To establish an international research network focused on elucidating the biological underpinnings of Parkinson's disease.
- To accelerate the discovery of Parkinson's disease origins and progression mechanisms.
- To foster collaborative research and promote open-science practices within the Parkinson's disease community.
Main Methods:
- Establishing a global consortium of researchers from diverse scientific disciplines.
- Incentivizing interdisciplinary collaboration through dedicated funding and shared resources.
- Implementing open-science principles to facilitate data sharing and knowledge dissemination.
Main Results:
- An international network of researchers is actively engaged in Parkinson's disease research.
- Enhanced collaboration between traditional PD researchers and experts from other fields is being fostered.
- Commitment to open-science practices is central to the initiative's operational framework.
Conclusions:
- The Aligning Science Across Parkinson's initiative is creating a collaborative ecosystem to advance Parkinson's disease research.
- Understanding the fundamental biology of Parkinson's disease is crucial for developing effective therapies.
- The initiative's focus on collaboration and open science is expected to accelerate therapeutic breakthroughs.
Related Concept Videos
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment
1000
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1000
Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K

